# Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

> **NCT00291785** · PHASE1,PHASE2 · COMPLETED · sponsor: **CTI BioPharma** · enrollment: 48 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** CT-2106
- **DRUG:** Folinic acid
- **DRUG:** 5-FU (fluorouracil)

## Key facts

- **NCT ID:** NCT00291785
- **Lead sponsor:** CTI BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-08
- **Final completion:** 2008-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291785, "Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00291785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*